Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Induction Phase	16	301
Total, all-cause mortality	Consolidation Phase	3	210
Total, all-cause mortality	Maintenance Phaase	0	93
Total, all-cause mortality	Overall	19	301
Total, other adverse events	Induction Phase	253	301
Total, other adverse events	Consolidation Phase	179	210
Total, other adverse events	Maintenance Phaase	48	93
Total, other adverse events	Overall	277	301
Total, serious adverse events	Induction Phase	76	301
Total, serious adverse events	Consolidation Phase	67	210
Total, serious adverse events	Maintenance Phaase	7	93
Total, serious adverse events	Overall	137	301

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03379727/event-totals